AliveCor develops the KardiaMobile 6L (six-lead) ECG to detect AFib and other heart rhythm conditions. The partnership aims to deliver KardiaMobile’s six-lead ECGs taken by patients directly into GE Healthcare’s MUSE cardiac management system for physicians to view and evaluate.
According to a news release, the companies believe integrating the technologies will offer physicians access to trusted patient data within their existing workflow, increasing diagnostic confidence and enhancing the management of patients across the care continuum. GE Healthcare and AliveCor partnered to reduce hospitalizations linked to cardiac conditions, including but not limited to AFib.
The AFib detection space continues to heat up, with iRhythm recently presenting research that backs its wearable ECG monitor against the traditional Holter monitor, while Bardy Diagnostics remains a player with its wearable patch.
GE Healthcare designed the MUSE platform as a vendor-agnostic offering for connecting a hospital’s electronic medical records (EMR) to manage and streamline the flow of cardiac information. By pairing MUSE with KardiaMobile, ECGs are not only analyzed by GE Healthcare’s algorithms, but they become part of the patient record within MUSE and the EMR so any physician within the network involved in the patient’s care can interact with them.
“By teaming up with AliveCor, we are strengthening the connection between personal health and clinical decision making to transform cardiac care to be more convenient for patients and actionable for providers,” GE Healthcare Life Care Solutions President and CEO Tom Westrick said in the release. “The KardiaMobile 6L allows patients to conveniently monitor their heart health in any environment, and by integrating its data directly into MUSE, we are offering hospitals and health systems an unprecedented amount of information to leverage for patient care within their existing clinical workflow – with the ultimate goal of improving patient outcomes and reducing the number of cardiac-related hospitalizations and the costs associated with them.”
The companies said that if a patient chooses to share a remote ECG from KardiaMobile, a physician sees the ECGs on a patient’s phone in an office visit or a PDF emailed by the patient. The data is not integrated into the clinical workflow, meaning a physician can’t easily compare the results to prior ECGs or relevant results from other diagnostic tools and tests.
Integration of the data into MUSE through GE Healthcare and AliveCor’s partnership allows for physicians to access prior ECGs or other relevant results, expanding diagnostic capabilities.
Physicians will prescribe or enroll KardiaMobile 6L for patients with certain cardiac diagnoses who can benefit from monitoring their condition and tracking their own ECG recordings at home or on the go. The hospital will issue a subscription linking the patient to its clinical desktop to use the KardiaMobile 6L. After an ECG is recorded, data automatically transfers from AliveCor’s cloud server directly into MUSE.
GE Healthcare said the new capabilities achieved through its partnership with AliveCor add to its Edison platform ecosystem, the AI-powered platform it plans to roll out.
“Delivering medically validated ECG readings taken with KardiaMobile 6L directly into MUSE can help facilitate closer connection and better communication about treatment and care between physicians and their patients, even when they are not physically together,” AliveCor CEO Priya Abani said. “This integration directly supports our mission of transforming cardiology with intelligent, highly personalized heart data and connected cardiac care services by offering providers information that can be integrated seamlessly into their clinical practices, and patients the convenience, privacy, and reliability of ECG readings they can perform at home or on the go.”
